All In MedTech

Device Trial Radar · NCT06506903

Avalus Ultra Post-Approval Study (PAS)

Last checked: Nov 19, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

190

Actual

Start

Nov 20, 2024

Primary completion

Nov 2026

Study completion Nov 2026

Sponsor

Lead sponsor
Medtronic Cardiac SurgeryPublic (MDT)
Sponsor type
Industry
First posted
Jul 18, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.

Conditions

  • Aortic Valve Disease

Interventions

  • Medtronic Avalus UltraDevice

    Surgical aortic valve replacement with the Medtronic Avalus Ultra bioprosthesis for management of aortic stenosis and regurgitation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time-related incidence of adverse events and death through 1 year post-procedureTime frame: 30 days and 1 year post-procedure
  2. Evaluation of Mean Pressure Gradient (mmHg) through 1 year post-procedureTime frame: 30 days and 1 year post-procedure
  3. Evaluation of Effective Orifice Area (cm^2) through 1 year post-procedureTime frame: 30 days and 1 year post-procedure

3 more outcomes with a free account

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Hartford Hospital

    Hartford, Connecticut

  • University of Florida Shands

    Gainesville, Florida

  • Emory Saint Joseph's

    Atlanta, Georgia

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.